Irinotecan Liposomes Combined With Bevacizumab in the Treatment of Recurrent Glioma

NCT06801730 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Glioma

Interventions

DRUG: Irinotecan liposome combined with bevacizumab

Sponsor

Zhifeng Tian,MD